GlassScriptPhysician profile
Meg E Zeringue
NPI 1336444546
$5,981.75
in general payments reported to CMS, 2019-2025
48 companies · $1,829 in 2025
The $1,829 reported for 2025 was more than what 92% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $257 · 2022: $664 · 2023: $1,628 · 2024: $1,603 · 2025: $1,829.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,767 · Education: $294.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,766.64 |
| Education | $293.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $488.39 | 2022-2025 | Keytruda, Lynparza, Keytruda Qlex |
| Pfizer INC. | $473.34 | 2022-2025 | |
| Astrazeneca Pharmaceuticals LP | $329.21 | 2023-2025 | Lynparza, Tagrisso, Imfinzi |
| Astellas Pharma US INC | $326.57 | 2021-2025 | Padcev, Xtandi |
| Beigene USA, INC. | $289.11 | 2023-2025 | Brukinsa, Tevimbra |
| Janssen Biotech, INC. | $264.74 | 2023-2025 | Darzalex, Talvey, Tecvayli |
| Daiichi Sankyo INC. | $248.08 | 2021-2025 | Enhertu, Injectafer, Datroway |
| Stemline Therapeutics INC. | $230.54 | 2023-2025 | Orserdu, Elzonris |
| Seagen INC. | $223.81 | 2021-2023 | Adcetris, Padcev, Tukysa |
| Gilead Sciences, INC. | $214.32 | 2022-2025 | Trodelvy |
| Abbvie INC. | $213.47 | 2024-2025 | |
| Novartis Pharmaceuticals Corporation | $186.32 | 2022-2025 | |
| Genentech USA, INC. | $172.27 | 2022-2024 | Polivy, Phesgo, Lunsumio |
| Lilly USA, LLC | $158.46 | 2022-2025 | Jaypirca, Verzenio, Retevmo |
| Bayer Healthcare Pharmaceuticals INC. | $150.15 | 2021-2025 |
Show all 48 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Meg Zeringue listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.